Pfizer Reports Strong First-Quarter Results And Reaffirms 2026 Guidance
| Show full article |
|
This functionality is available for registred users only
|
-
Full namePfizer Inc
-
Registration countryUSA
-
IndustryPharmaceutical Preparation and Biotechnology
-
М/S&P/F
*** /*** /***









